VaxGen Inc. expects to fund its operations through the end of next year by selling its stake in an overseas contract manufacturing firm. (BioWorld Today)

VaxGen Inc. expects to fund its operations through the end of next year by selling its stake in an overseas contract manufacturing firm. (BioWorld Today)

Poor Celacade data sank shares of Vasogen Inc., though the company s top executive pointed to a bit of silver lining in this story. (BioWorld Today)